Pathological Gambling Clinical Trial
— PERHAPSOfficial title:
Poker, Skills and Associated Problems (PERHAPS). Controlled Experimental Single Centre Study of Poker Players: Study of the Cognitive Mechanisms Underlying Poker Skills and of the Specificity of Poker-related Problems
Verified date | March 2021 |
Source | Nantes University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The PERHAPS project aims to fill two gaps in the scientific literature: on the one hand, studying the clinical and cognitive particularities of poker-related problems, and on the other hand, studying poker skill as a combination of multiple cognitive and emotional abilities. The underlying clinical aim is to develop a cognitive remediation therapy program dedicated to pathological gamblers.
Status | Completed |
Enrollment | 113 |
Est. completion date | March 23, 2021 |
Est. primary completion date | March 23, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 59 Years |
Eligibility | Inclusion Criteria: - 18-59 years - good understanding of French, literate - correct level of vision and hearing - specific inclusion criteria for each group include frequency and length of poker practice, DSM-5 doagnostic criteria for gambling disorder Exclusion Criteria: - protected adults - important cognitive deficit (assessed by the MMSE) - psychotic syndrome whole life - other psychiatric disorders (mood disorders, anxiety disorders) and addictive disorders (disorders related to the use of alcoholic or other substances, excluding nicotine) that are present and not stabilized - unstable endocrine disorders - significant neurological disorders (such as head injuries (except mild), neurodegenerative diseases, unbalanced epilepsy, mental retardation, etc.) - psychoactive use (before participation) - color blindness - cardiac disorders - electronic implants |
Country | Name | City | State |
---|---|---|---|
France | CHU de Nantes | Nantes |
Lead Sponsor | Collaborator |
---|---|
Nantes University Hospital |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | attention and emotional perception performances | Modified Posner paradigm Performances will be compared between pathological poker players and non-poker players (to identify cognitive deficits in pathological players compared to baseline level) and between pathological poker players and expert unproblematic poker players (to identify cognitive deficits in pathological players compared to a gambler level) | only one assessment so at baseline | |
Primary | mental flexibility performances | Wisconsin Test (M-WCST) Performances will be compared between pathological poker players and non-poker players (to identify cognitive deficits in pathological players compared to baseline level) and between pathological poker players and expert unproblematic poker players (to identify cognitive deficits in pathological players compared to a gambler level) | only one assessment so at baseline | |
Primary | inhibition performances | Evaluation of inhibition at verbal level: Hayling sentence Completion Task Performances will be compared between pathological poker players and non-poker players (to identify cognitive deficits in pathological players compared to baseline level) | only one assessment so at baseline | |
Primary | inhibition performances | Evaluation of inhibition at motor level : Go-No Go Task Performances will be compared between pathological poker players and non-poker players (to identify cognitive deficits in pathological players compared to baseline level) | only one assessment so at baseline | |
Primary | inhibition performances | Evaluation of inhibition et expressive level : suppressive expression method Performances will be compared between pathological poker players and non-poker players (to identify cognitive deficits in pathological players compared to baseline level) | only one assessment so at baseline | |
Secondary | gambling course and habits | Standardized maintenance grid. The interview allows you to explore gambling habits, possible abstinence periods, different games the game of choice, current practice, damage and the quality of shoring, and resources. | only one assessment so at baseline | |
Secondary | control attribution (locus of control) | three-dimensional control location scale of Levenson (IPAH) | only one assessment so at baseline | |
Secondary | level of cognitive distortions, | clinical questionnaires : Gambling Related Cognitions Scale (GRCS) | only one assessment so at baseline | |
Secondary | level of social phobia | clinical questionnaires : social phobia questionnaire Leibowitz, | only one assessment so at baseline | |
Secondary | motivation for gambling | clinical questionnaires : Gambling motivation questionnaire Reasons Questionnaire (GMQ) | only one assessment so at baseline | |
Secondary | impulsivity profile | clinical questionnaires : Impulsive Behavior Scale | only one assessment so at baseline | |
Secondary | psychiatric and addictive comorbidities | clinical questionnaires : Mini International Neuropsychiatric Interview (MINI) | only one assessment so at baseline | |
Secondary | coping and gambling related-damage | clinical questionnaires : COPE Brief Questionnaire | only one assessment so at baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02203786 -
D1 and D2 Dopamine Receptors in Gambling and Amphetamine Reinforcement
|
Phase 2 | |
Completed |
NCT05051085 -
Feasibility of the Internet-delivered Treatment "SpilleFri" for Patients With Pathological Gambling
|
N/A | |
Completed |
NCT01215357 -
Clinical Study to Determine if Ecopipam Can Reduce Urges to Gamble
|
Phase 2 | |
Terminated |
NCT00245583 -
Topiramate in the Treatment of Pathological Gambling
|
Phase 3 | |
Completed |
NCT04842461 -
Mental Health, Addictions and Biomarkers in High Athletes Performance
|
||
Not yet recruiting |
NCT03280966 -
Effects of Intranasal Naloxone on Gambling Urges in Gambling Disorder
|
Phase 2 | |
Active, not recruiting |
NCT01743092 -
Testing Resources: Manual and Webinar Guided Treatment vs. Manual Guided Treatment
|
N/A | |
Active, not recruiting |
NCT01528982 -
Susceptibility to Pathological Gambling
|
N/A | |
Terminated |
NCT00211822 -
Functional Magnetic Resonance Imaging (fMRI) Studies in Pathological Gambling (PG) and Obsessive-Compulsive Disorder (OCD)
|
N/A | |
Completed |
NCT01381250 -
Effects of Internet-based Treatment of Pathological Gambling
|
N/A | |
Completed |
NCT05506384 -
Treatment Study for Problematic Gaming and Gambling
|
N/A | |
Enrolling by invitation |
NCT03464838 -
Effects of Transcranial Direct Current Stimulation (tDCS) in Gambling Disorder
|
N/A | |
Terminated |
NCT01560351 -
Repeated Low-frequency Transcranial Magnetic Stimulation Reduces Cue-induced Craving: a Randomized, Prospective, Double-blind, Sham-controlled, Cross-over Study
|
N/A | |
Completed |
NCT00580567 -
Impulsivity in Pathological Gambling
|
N/A | |
Completed |
NCT02240485 -
Integrative Couple Treatment for Pathological Gambling
|
N/A | |
Withdrawn |
NCT01340274 -
Community Reinforcement Approach and Family Training (CRAFT) for Problem Gambling
|
Phase 2 | |
Recruiting |
NCT02491996 -
The Efficacy of Therapy Focused on Desire-satisfaction for Disordered Gamblers
|
N/A | |
Recruiting |
NCT01154712 -
Deep Low-Frequency Repetitive Transcranial Magnetic Stimulation for Cessation of Pathological Gambling
|
Phase 1 | |
Completed |
NCT00927563 -
Tolcapone Treatment of Pathological Gambling
|
Phase 2 | |
Completed |
NCT01843699 -
Topiramate Trial for Pathological Gamblers
|
Phase 2 |